Altimmune, Inc. financial data

Symbol
ALT on Nasdaq
Location
Gaithersburg, MD
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 06 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1657% % 9.7%
Debt-to-equity 15% % 47%
Return On Equity -55% % 14%
Return On Assets -48% % 17%
Operating Margin -452310% % -110%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 104,254,173 shares 47%
Common Stock, Shares, Outstanding 95,598,665 shares 34%
Entity Public Float $469,000,000 USD 154%
Common Stock, Value, Issued $10,000 USD 43%
Weighted Average Number of Shares Outstanding, Basic 89,418,028 shares 26%
Weighted Average Number of Shares Outstanding, Diluted 89,418,028 shares 26%

Income Statement

Label TTM Value / Value Unit Change %
Revenues $20,000 USD -62%
Research and Development Expense $67,804,000 USD -15%
General and Administrative Expense $22,678,000 USD 12%
Operating Income (Loss) $90,462,000 USD 19%
Nonoperating Income (Expense) $5,866,000 USD -30%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $84,596,000 USD 17%
Income Tax Expense (Benefit) $681,000 USD
Net Income (Loss) Attributable to Parent $83,915,000 USD 19%
Earnings Per Share, Basic -1 USD/shares 31%
Earnings Per Share, Diluted -1 USD/shares 31%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $61,236,000 USD 95%
Assets, Current $216,615,000 USD 49%
Property, Plant and Equipment, Net $337,000 USD -24%
Operating Lease, Right-of-Use Asset $1,639,000 USD 352%
Intangible Assets, Net (Excluding Goodwill) $0 USD
Other Assets, Noncurrent $1,495,000 USD -9.9%
Assets $218,447,000 USD 48%
Accounts Payable, Current $4,804,000 USD 324%
Employee-related Liabilities, Current $2,411,000 USD 4.2%
Liabilities, Current $12,606,000 USD 46%
Operating Lease, Liability, Noncurrent $1,213,000 USD -17%
Other Liabilities, Noncurrent $5,795,000 USD 22188%
Liabilities $32,846,000 USD 127%
Accumulated Other Comprehensive Income (Loss), Net of Tax $5,016,000 USD -3.5%
Retained Earnings (Accumulated Deficit) $622,125,000 USD -16%
Stockholders' Equity Attributable to Parent $185,601,000 USD 39%
Liabilities and Equity $218,447,000 USD 48%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $16,840,000 USD -3%
Net Cash Provided by (Used in) Financing Activities $34,119,000 USD
Net Cash Provided by (Used in) Investing Activities $5,101,000 USD 87%
Common Stock, Shares Authorized 200,000,000 shares 0%
Common Stock, Shares, Issued 95,598,665 shares 34%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $12,178,000 USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $61,278,000 USD 94%
Deferred Tax Assets, Valuation Allowance $106,423,000 USD 28%
Deferred Tax Assets, Gross $106,874,000 USD 29%
Operating Lease, Liability $1,681,000 USD 151%
Depreciation $29,000 USD -73%
Lessee, Operating Lease, Liability, to be Paid $2,131,000 USD 204%
Property, Plant and Equipment, Gross $2,626,000 USD 0%
Operating Lease, Liability, Current $247,000 USD -21%
Lessee, Operating Lease, Liability, to be Paid, Year Two $376,000 USD 114%
Lessee, Operating Lease, Liability, to be Paid, Year One $422,000 USD -20%
Operating Lease, Weighted Average Discount Rate, Percent 0.1 pure 28%
Deferred Income Tax Expense (Benefit) $681,000 USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $450,000 USD 1352%
Lessee, Operating Lease, Liability, to be Paid, Year Three $387,000 USD
Deferred Tax Assets, Operating Loss Carryforwards $64,779,000 USD 20%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 1,000,000 shares 0%
Unrecognized Tax Benefits $700,000 USD 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four $398,000 USD
Operating Lease, Payments $100,000 USD 0%
Additional Paid in Capital $812,732,000 USD 20%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance $451,000 USD 360%
Share-based Payment Arrangement, Expense $14,489,000 USD 7.3%
Interest Expense $34,000 USD -50%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%